<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-054342</identifier>
<setSpec>1699-8855</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">GIST tumors. A literature review</dc:title>
<dc:description xml:lang="en">GIST is the most common mesenchymal tumor in the    digestive tract. The mayority of them has characteristic    gain-of-function mutations of the c-kit gene, which encodes    the KIT Receptor for stem cell factor. The specific identification    of GIST has become more important after the availability    of KIT-selective tyrosine kinase inhibitor Imatinib    mesylate, STI571, commercially known as Gleevec (Novartis-    Pharma, Basel, Switzerland) in the treatment of unresectable    and metastatic tumors.    The purpose of this article is to review data of the pathology,    prognosis and management of GIST</dc:description>
<dc:creator>Eizaguirre Zarza, Beatriz</dc:creator>
<dc:creator>Burgos Bretones, Juan José</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El tumor estromal gastrointestinal (GIST) es el tumor    mesenquimal más frecuente en el tracto digestivo. La mayoría    de los GIST poseen una característica mutación con    ganancia de función del gen c-KIT, que codifica el receptor    KIT para el factor de células Stem. El reconocimiento de    este tumor ha adquirido más importancia tras la disponibilidad    de un inhibidor de la tirosina quinasa KIT, mesilato de    Imatinib, llamado comercialmente Glivec (Novartis-Pharma,    Basilea, Suiza), en el tratamiento de los tumores metastásicos    e irresecables.    El propósito de este trabajo es la revisión de la patología,    pronóstico y tratamiento de los tumores GIST</dc:description>
<dc:source>Rev. esp. patol;39(4): 209-218, oct.-dic.2006. ilus, tab</dc:source>
<dc:identifier>ibc-054342</dc:identifier>
<dc:title xml:lang="es">Tumores GIST. Revisión de la literatura</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d24373</dc:subject>
<dc:subject>^d5911^s22016</dc:subject>
<dc:subject>^d19589^s22073</dc:subject>
<dc:subject>^d5911^s22033</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d5911^s22053</dc:subject>
<dc:subject>^d32639^s22033</dc:subject>
<dc:subject>^d5911^s22009</dc:subject>
<dc:type>article</dc:type>
<dc:date>200612</dc:date>
</metadata>
</record>
</ibecs-document>
